Your browser doesn't support javascript.
loading
The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
Musarrat, Farhana; Chouljenko, Vladimir; Dahal, Achyut; Nabi, Rafiq; Chouljenko, Tamara; Jois, Seetharama D; Kousoulas, Konstantin G.
Afiliação
  • Musarrat F; Division of Biotechnology and Molecular Medicine, Louisiana State University, Baton Rouge, Louisiana.
  • Chouljenko V; Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana.
  • Dahal A; Division of Biotechnology and Molecular Medicine, Louisiana State University, Baton Rouge, Louisiana.
  • Nabi R; Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana.
  • Chouljenko T; School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, Louisiana.
  • Jois SD; Division of Biotechnology and Molecular Medicine, Louisiana State University, Baton Rouge, Louisiana.
  • Kousoulas KG; Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana.
J Med Virol ; 92(10): 2087-2095, 2020 10.
Article em En | MEDLINE | ID: mdl-32374457

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / Nelfinavir / Coronavírus Relacionado à Síndrome Respiratória Aguda Grave / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / Fusão de Membrana Limite: Animals / Humans Idioma: En Revista: J Med Virol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Anti-HIV / Nelfinavir / Coronavírus Relacionado à Síndrome Respiratória Aguda Grave / Glicoproteína da Espícula de Coronavírus / SARS-CoV-2 / Fusão de Membrana Limite: Animals / Humans Idioma: En Revista: J Med Virol Ano de publicação: 2020 Tipo de documento: Article